Updated 02/26/2018 New Studies
Lung diseases range from mild to severe, but affect thousands of people in America every year. COPD (Chronic Obstructive Pulmonary Disease) is the third leading cause of death in the United States. About 1 in 12 people in the U.S. suffer from asthma. According to the Centers for Disease Control and Prevention, 212,584 people in the United States were diagnosed with lung cancer in 2013. The types of treatment most commonly available are surgery, chemotherapy, radiation therapy, or targeted therapy, which is the use of prescription drugs. As time goes on, society is starting to notice a wider acceptance of natural medicines and the lack of support behind prescription drugs and standard practices. Many people are turning to CBD for help.
Cannabidiol has demonstrated strong anti-inflammatory effect in clinical trials, and this suggests that it can improve lung function in those with acute lung injury. These trials and studies are now indicating that it may be a viable treatment option for inflammatory lung diseases, according to a new study published in the journal Immunopharmacology Immunotoxicology. Cannabis has been used for thousands of years for a wide scope of medicinal purposes. However, it is finally beginning to gain attention and support by the masses. Currently there are several ongoing studies specifically focusing on the relationship between CBD and lung diseases across the board.
In the latest study, published in the open-access journal PLOS One, researchers from Brazil and Germany were able to protect mice from acute lung injury by increasing levels of one of the body’s own cannabinoids, 2-AG (2-Arachidonoylglycerol). By activating cannabinoids receptors, scientist are able to control the immune system, which is a large factor in most inflammatory diseases, including acute lung injury. Since immune cells travel through the blood stream, cannabinoids could be used in treatment without having to inhale smoke. While the results need to be confirmed in humans, the team concludes that targeting cannabinoid pathways of the body could be “a useful therapeutic tool for the treatment of inflammatory lung diseases.”
The most recent study was approved in October, 2017. This trial was a human clinical trial done that examined 2,982 individuals between November of 2011- January of 2015. The individuals were volunteer recruits, and were between the ages of 40-80. The study involved several factors such as number of cigarettes smoked, amount of cannabis consumed, as well as other lung function criteria. The study results showed that people who often exercise their endocannabinoid system are more active and are less likely to develop COPD or lung disease.
For those who aren't able to purchase medical cannabis due to their state laws, hemp-derived CBD oil is a popular alternative option. Since many people with lung injuries or diseases are not able to comfortably inhale, a good starting point might be CBD oil capsules, or CBD oil tinctures. There are actually a number of unique methods of consumption of cannabinoids.
Do you have a question or comment about CBD? Let us know, and we will respond right away. In the meantime, sign up for our newsletters and visit our website DiscoverCBD.com regularly for the latest updates on research, legislation, and other news impacting you and cannabidiol.
Thank you for taking the time to read our blog! To get your very own Active CBD products, come into any one of our Discover CBD stores, on the web at discovercbd.com, facebook, or by simply calling us at, 719-358-7553 to place an order!
